Bone Biologics's total assets for Q4 2025 were $5.80M, a decrease of -8.73% from the previous quarter. BBLG total liabilities were $418.59K for the fiscal quarter, a 25.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.